The role of Elective Neck Dissection (END) in patients with Sinonasal Carcinoma and clinical N0 neck
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S313
DOI: 10.1055/s-0044-1785057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Manuela Burggraf und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The management of patients with sinonasal cancer and clinical N0 neck is still discussed. In the past years the rate of elective neck dissection (END) in N0 patients has increased and there are studies which show improved locoregional control for patients who underwent END. However, END increases the perioperative risk and it"s benefit on overall survival is still unclear.
Methods
We retrospectively searched our patient management system for patients with sinonasal malignancies since 2012. Relevant details were amongst others N-status, therapy with or without END, and recurrence. Statistics was performed using SPSS. The study was approved by the Institutional Ethics Committee of Ludwig-Maximilians-University.
Results
129 patients were included, 119 were treated with curative intent. In total, 14 of 96 N0 patients (14.6%) received surgical treatment of the neck (END or lymph node extirpation). In 2 cases (14.3%) histological results showed occult lymph node metastases (LNM). Lymph node recurrence occurred in 1 of 14 N0 (7.1%) patients after surgical treatment of the neck. Among the patients which did not receive any surgical treatment of the neck, 4 of 82 N0 patients (4.9%) developed lymph node recurrence.
Discussion
In patients with sinonasal malignancies LNM are an important negative prognostic factor. The detection of occult LNM therefore presents a particular challenge and is decisive for the prognosis and the course of disease.[ZJ1] The rate of occult LNM in our data was 6%. Consequently, END for N0 patients seems to be overtreatment and should not be performed as standard therap. However, sentinel lymph node biopsy could be a less invasive procedure to detect occult LNM and thus identify patients for two-stage neck dissection. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Burggraf, M., Elawany, N., Thölken, R., Thölken, K., Zenk, J., & Döscher, J. (2024). The role of Elective Neck Dissection (END) in patients with Sinonasal Carcinoma and clinical N0 neck. Laryngo-Rhino-Otologie, 103(S 02 S 02), S313. https://doi.org/10.1055/s-0044-1785057
Vancouver
Burggraf M, Elawany N, Thölken R, Thölken K, Zenk J, Döscher J. The role of Elective Neck Dissection (END) in patients with Sinonasal Carcinoma and clinical N0 neck. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S313. doi:10.1055/s-0044-1785057
BibTeX
@article{Burggraf2024,
author = {Burggraf, Manuela and Elawany, Noran and Thölken, Rubens and Thölken, Karisa and Zenk, Johannes and Döscher, Johannes},
title = {The role of Elective Neck Dissection (END) in patients with Sinonasal Carcinoma and clinical N0 neck},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S313},
doi = {10.1055/s-0044-1785057}
}
EUVIMED